Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 2 Vaccination parameters

From: Burden of paediatric Rotavirus Gastroenteritis (RVGE) and potential benefits of a universal Rotavirus vaccination programme with a pentavalent vaccine in Spain

Parameters Value Source
Coverage rate 90% 20
Vaccine efficacy (%):   
Hospitalizations reduction 95.80 16
Emergency visits reduction 93.70 16
PCC visits reduction 86.00 16
Nosocomial infections reduction 95.80 Assumption: same as hospitalization
Cases not seeking care reduction 86.00 Assumption: same as PCC
Waning rate after 2 years 10% Based on REST (16) and expert opinions